Published in Gastroenterology on October 01, 1989
Transcriptional activation of the H-ferritin gene in differentiated Caco-2 cells parallels a change in the activity of the nuclear factor Bbf. Biochem J (1995) 0.84
Polyamine metabolism of enterocyte-like Caco-2 cells after exposure to Phaseolus vulgaris lectin. Gut (1996) 0.76
Cell kinetics and polyamine enzymes in the intestinal mucosa of rats with azoxymethane induced tumours. Int J Exp Pathol (1994) 0.76
Radiofrequency ablation of unresectable primary and metastatic hepatic malignancies: results in 123 patients. Ann Surg (1999) 5.25
Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor. Clin Cancer Res (2000) 3.95
Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor. Clin Cancer Res (2001) 2.29
BRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cells. Br J Cancer (2003) 2.26
Two mutations of BRCA2 gene at exon and splicing site in a woman who underwent oncogenetic counseling. Ann Oncol (2009) 2.13
Familial papillary thyroid microcarcinoma: a new clinical entity. Lancet (1999) 1.98
Imaging congenital optic disc pits and associated maculopathy using optical coherence tomography. Arch Ophthalmol (1996) 1.94
Pulsed Doppler echocardiographic determination of time of ductal closure in normal newborn infants. J Pediatr (1981) 1.89
Demonstration that monocytes rather than lymphocytes are the insulin-binding cells in preparations of humah peripheral blood mononuclear leukocytes: implications for studies of insulin-resistant states in man. Proc Natl Acad Sci U S A (1975) 1.83
Antiangiogenic and antitumor activity of anti-epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense oligonucleotide in human GEO colon cancer cells. Clin Cancer Res (2000) 1.82
c-erb B2 overexpression decreases the benefit of adjuvant tamoxifen in early-stage breast cancer without axillary lymph node metastases. J Clin Oncol (1996) 1.74
Prophylaxis and treatment of hepatitis B in immunocompromised patients. Dig Liver Dis (2007) 1.73
Antitumor activity of sequential treatment with topotecan and anti-epidermal growth factor receptor monoclonal antibody C225. Clin Cancer Res (1999) 1.66
Oral glutamine in the prevention of fluorouracil induced intestinal toxicity: a double blind, placebo controlled, randomised trial. Gut (2001) 1.61
A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients. Br J Cancer (2005) 1.61
Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small-cell lung cancer: amphiregulin and microvessel count are independent prognostic indicators of survival. Clin Cancer Res (1998) 1.54
Orocecal transit time and bacterial overgrowth in patients with Crohn's disease. J Clin Gastroenterol (2000) 1.52
Soluble interleukin-2 receptor levels in hepatocellular cancer: a more sensitive marker than alfa fetoprotein. Ann Surg Oncol (1999) 1.51
Celiac disease and pregnancy outcome. Am J Gastroenterol (1996) 1.43
Thallium-201 per rectum for the diagnosis of cirrhosis in patients with asymptomatic chronic hepatitis. Hepatology (1988) 1.42
Antimyosin antibody imaging in experimental aortic regurgitation. J Nucl Cardiol (1997) 1.42
Hypocalciuria in overt and subclinical celiac disease. Am J Gastroenterol (1995) 1.41
Villous adenoma of the rectum associated with malabsorption. J Clin Gastroenterol (1991) 1.41
Cisplatin and vinorelbine as neoadjuvant chemotherapy in locally advanced cervical cancer: a phase II study. Int J Gynecol Cancer (2003) 1.41
miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1. Cell Death Dis (2012) 1.40
Beclomethasone dipropionate (3 mg) enemas combined with oral 5-ASA (2.4 g) in the treatment of ulcerative colitis not responsive to oral 5-ASA alone. Ital J Gastroenterol Hepatol (1998) 1.40
The history of Helicobacter pylori: a reflection on the relationship between the medical community and industry. Dig Liver Dis (2006) 1.39
Clinical efficacy and safety of cisapride and clebopride in the management of chronic functional dyspepsia: a double-blind, randomized study. Ital J Gastroenterol (1991) 1.39
Multiple sclerosis and non-communicating syringomyelia: a casual association or linked diseases? Acta Neurol Scand (1999) 1.38
A unique three-dimensional SCID-polymeric scaffold (SCID-synth-hu) model for in vivo expansion of human primary multiple myeloma cells. Leukemia (2011) 1.38
Small volume isosmotic polyethylene glycol electrolyte balanced solution (PMF-100) in treatment of chronic nonorganic constipation. Dig Dis Sci (1996) 1.35
Gender and clinical presentation in adult celiac disease. Scand J Gastroenterol (1995) 1.31
Selecting high-risk early breast cancer patients: what to add to the number of metastatic nodes? Eur J Cancer (1996) 1.26
Concomitant CXCR4 and CXCR7 expression predicts poor prognosis in renal cancer. Curr Cancer Drug Targets (2010) 1.25
Zoledronic acid induces antiproliferative and apoptotic effects in human pancreatic cancer cells in vitro. Br J Cancer (2003) 1.21
Goserelin depot in the treatment of premenopausal advanced breast cancer. Eur J Cancer (1992) 1.17
Additive effects of c-erbB-2, c-Ha-ras, and transforming growth factor-alpha genes on in vitro transformation of human mammary epithelial cells. Mol Carcinog (1992) 1.17
Depressive symptoms in adult coeliac disease. Scand J Gastroenterol (1998) 1.14
Antitumor activity of combined blockade of epidermal growth factor receptor and protein kinase A. J Natl Cancer Inst (1996) 1.13
Interferon-alpha induces apoptosis in human KB cells through a stress-dependent mitogen activated protein kinase pathway that is antagonized by epidermal growth factor. Cell Death Differ (1999) 1.13
HLA class II favors clearance of HCV infection and progression of the chronic liver damage. J Hepatol (1999) 1.13
Primary mucinous adenocarcinomas and signet-ring cell carcinomas of colon and rectum. Oncology (1994) 1.13
Colonoscopic removal of a polypoid arteriovenous malformation. Dig Liver Dis (2001) 1.12
The complete structure of the rat thyroglobulin gene. Proc Natl Acad Sci U S A (1986) 1.12
Emerging strategies to strengthen the anti-tumour activity of type I interferons: overcoming survival pathways. Curr Cancer Drug Targets (2009) 1.10
Phase II study of gefitinib in combination with docetaxel as first-line therapy in metastatic breast cancer. Br J Cancer (2006) 1.09
The eukaryotic initiation factor 5A is involved in the regulation of proliferation and apoptosis induced by interferon-alpha and EGF in human cancer cells. J Biochem (2003) 1.09
Clinical and neurological abnormalities in adult celiac disease. Neurol Sci (2003) 1.08
Effect of pregnancy on the clinical course of a cohort of women with inflammatory bowel disease. Ital J Gastroenterol (1996) 1.08
Phase III multicenter randomized trial of amifostine as cytoprotectant in first-line chemotherapy in ovarian cancer patients. Ann Oncol (2003) 1.06
Microscopic inflammatory changes in colon of patients with both active psoriasis and psoriatic arthritis without bowel symptoms. J Rheumatol (2000) 1.05
Butyrate enemas in experimental colitis and protection against large bowel cancer in a rat model. Gastroenterology (1996) 1.05
The ATAC ('Arimidex', Tamoxifen, Alone or in Combination) adjuvant breast cancer trial: first results of the endometrial sub-protocol following 2 years of treatment. Hum Reprod (2005) 1.05
Isoprenylation of intracellular proteins as a new target for the therapy of human neoplasms: preclinical and clinical implications. Curr Drug Targets (2005) 1.03
The Italian multi-centre project on evaluation of MRI and other imaging modalities in early detection of breast cancer in subjects at high genetic risk. J Exp Clin Cancer Res (2002) 1.02
Antitumor activity of combined treatment of human cancer cells with ionizing radiation and anti-epidermal growth factor receptor monoclonal antibody C225 plus type I protein kinase A antisense oligonucleotide. Clin Cancer Res (2000) 1.02
The arthritis of coeliac disease: prevalence and pattern in 200 adult patients. Br J Rheumatol (1996) 1.02
Growth inhibition and synergistic induction of apoptosis by zoledronate and dexamethasone in human myeloma cell lines. Leukemia (2000) 1.02
Health-related quality of life in recurrent platinum-sensitive ovarian cancer--results from the CALYPSO trial. Ann Oncol (2012) 1.01
C-Raf antagonizes apoptosis induced by IFN-alpha in human lung cancer cells by phosphorylation and increase of the intracellular content of elongation factor 1A. Cell Death Differ (2007) 1.01
The RIalpha subunit of protein kinase A (PKA) binds to Grb2 and allows PKA interaction with the activated EGF-receptor. Oncogene (1997) 1.00
Opposite polarity of virus budding and of viral envelope glycoprotein distribution in epithelial cells derived from different tissues. J Cell Biol (1992) 1.00
Abnormal esophageal acid exposure is common in morbidly obese patients and improves after a successful Lap-band system implantation. Surg Endosc (2002) 1.00
Fibromyalgia in patients with irritable bowel syndrome. An association with the severity of the intestinal disorder. Int J Colorectal Dis (2001) 0.99
Differential immunohistochemical detection of transforming growth factor alpha, amphiregulin and CRIPTO in human normal and malignant breast tissues. Int J Cancer (1996) 0.99
Helicobacter pylori impairs iron absorption in infected individuals. Dig Liver Dis (2004) 0.99
Interferon alpha-2b at low doses as long-term antiangiogenic treatment of a metastatic intracranial hemangioendothelioma: a case report. Oncol Rep (2000) 0.99
Antibiotic treatment of small bowel bacterial overgrowth in patients with Crohn's disease. Aliment Pharmacol Ther (2003) 0.98
Metastases to the breast: role of fine needle cytology samples. Our experience with nine cases in 2 years. Ann Oncol (2007) 0.98
Cetuximab ± chemotherapy enhances dendritic cell-mediated phagocytosis of colon cancer cells and ignites a highly efficient colon cancer antigen-specific cytotoxic T-cell response in vitro. Int J Cancer (2011) 0.97
Current approaches and perspectives in the therapy of medullary thyroid carcinoma. Cancer (2001) 0.97
Mouse models as a translational platform for the development of new therapeutic agents in multiple myeloma. Curr Cancer Drug Targets (2012) 0.97
Effects of dietary treatment on bone mineral density in adults with celiac disease: factors predicting response. Am J Gastroenterol (1997) 0.97
Deregulation of HOX B13 expression in urinary bladder cancer progression. Curr Med Chem (2013) 0.96
Survival data relating to the use of goserelin depot in the treatment of premenopausal advanced breast cancer. Eur J Cancer (1993) 0.96
Cloning and expression of laminin alpha 2 chain (M-chain) in the mouse. Matrix Biol (1995) 0.95
Postheparin plasma diamine oxidase in subjects with small bowel mucosal atrophy. Dig Dis Sci (1987) 0.95
Site-selective cyclic AMP analogs provide a new approach in the control of cancer cell growth. FEBS Lett (1987) 0.94
Gemcitabine combined with continuous infusion 5-fluorouracil in advanced and symptomatic pancreatic cancer: a clinical benefit-oriented phase II study. Br J Cancer (2000) 0.94
Direct evidence of oxidative damage in acute and chronic phases of experimental colitis in rats. Dig Dis Sci (1996) 0.93
Vinorelbine is well tolerated and active in the treatment of elderly patients with advanced non-small cell lung cancer. A two-stage phase II study. Eur J Cancer (1997) 0.93
Interferon alpha2 recombinant and epidermal growth factor modulate proliferation and hypusine synthesis in human epidermoid cancer KB cells. Biochem J (1997) 0.93
Slow release lanreotide in combination with interferon-alpha2b in the treatment of symptomatic advanced medullary thyroid carcinoma. J Clin Endocrinol Metab (2000) 0.93
Placebo controlled studies with ranitidine in duodenal ulcer. Scand J Gastroenterol Suppl (1981) 0.92
Diamine oxidase in rat small bowel: distribution in different segments and cellular location. Enzyme (1984) 0.92
8-Chloro-cyclic AMP inhibits autocrine and angiogenic growth factor production in human colorectal and breast cancer. Clin Cancer Res (1997) 0.92